Single-Use Technologies for the Biologic-Global Market Status and Trend Report 2016-2026
Table of Contents
Chapter 1 Overview of Single-Use Technologies for the Biologic
- 1.1 Definition of Single-Use Technologies for the Biologic in This Report
- 1.2 Commercial Types of Single-Use Technologies for the Biologic
- 1.2.1 Membrane Adsorber
- 1.2.2 Bioreactors
- 1.2.3 Disposable Mixing Systems
- 1.2.4 Tangential Flow Filtration
- 1.2.5 Tubing and Connectors
- 1.2.6 Depth Filtration
- 1.2.7 Buffer Containers
- 1.2.8 Waste Containers
- 1.3 Downstream Application of Single-Use Technologies for the Biologic
- 1.3.1 Monoclonal Antibodies
- 1.3.2 Vaccines
- 1.3.3 Gene Therapy
- 1.3.4 Recombinant Proteins
- 1.3.5 Blood Derivatives
- 1.4 Development History of Single-Use Technologies for the Biologic
- 1.5 Market Status and Trend of Single-Use Technologies for the Biologic 2016-2026
- 1.5.1 Global Single-Use Technologies for the Biologic Market Status and Trend 2016-2026
- 1.5.2 Regional Single-Use Technologies for the Biologic Market Status and Trend 2016-2026
Chapter 2 Global Market Status and Forecast by Regions
- 2.1 Market Development of Single-Use Technologies for the Biologic 2016-2021
- 2.2 Production Market of Single-Use Technologies for the Biologic by Regions
- 2.2.1 Production Volume of Single-Use Technologies for the Biologic by Regions
- 2.2.2 Production Value of Single-Use Technologies for the Biologic by Regions
- 2.3 Demand Market of Single-Use Technologies for the Biologic by Regions
- 2.4 Production and Demand Status of Single-Use Technologies for the Biologic by Regions
- 2.4.1 Production and Demand Status of Single-Use Technologies for the Biologic by Regions 2016-2021
- 2.4.2 Import and Export Status of Single-Use Technologies for the Biologic by Regions 2016-2021
Chapter 3 Global Market Status and Forecast by Types
- 3.1 Production Volume of Single-Use Technologies for the Biologic by Types
- 3.2 Production Value of Single-Use Technologies for the Biologic by Types
- 3.3 Market Forecast of Single-Use Technologies for the Biologic by Types
Chapter 4 Global Market Status and Forecast by Downstream Industry
- 4.1 Demand Volume of Single-Use Technologies for the Biologic by Downstream Industry
- 4.2 Market Forecast of Single-Use Technologies for the Biologic by Downstream Industry
Chapter 5 Market Driving Factor Analysis of Single-Use Technologies for the Biologic
- 5.1 Global Economy Situation and Trend Overview
- 5.2 Single-Use Technologies for the Biologic Downstream Industry Situation and Trend Overview
Chapter 6 Single-Use Technologies for the Biologic Market Competition Status by Major Manufacturers
- 6.1 Production Volume of Single-Use Technologies for the Biologic by Major Manufacturers
- 6.2 Production Value of Single-Use Technologies for the Biologic by Major Manufacturers
- 6.3 Basic Information of Single-Use Technologies for the Biologic by Major Manufacturers
- 6.3.1 Headquarters Location and Established Time of Single-Use Technologies for the Biologic Major Manufacturer
- 6.3.2 Employees and Revenue Level of Single-Use Technologies for the Biologic Major Manufacturer
- 6.4 Market Competition News and Trend
- 6.4.1 Merger, Consolidation or Acquisition News
- 6.4.2 Investment or Disinvestment News
- 6.4.3 New Product Development and Launch
Chapter 7 Single-Use Technologies for the Biologic Major Manufacturers Introduction and Market Data
- 7.1 Thermo Fisher Scientific
- 7.1.1 Company profile
- 7.1.2 Representative Single-Use Technologies for the Biologic Product
- 7.1.3 Single-Use Technologies for the Biologic Sales, Revenue, Price and Gross Margin of Thermo Fisher Scientific
- 7.2 Applikon Biotechnology
- 7.2.1 Company profile
- 7.2.2 Representative Single-Use Technologies for the Biologic Product
- 7.2.3 Single-Use Technologies for the Biologic Sales, Revenue, Price and Gross Margin of Applikon Biotechnology
- 7.3 GE Healthcare
- 7.3.1 Company profile
- 7.3.2 Representative Single-Use Technologies for the Biologic Product
- 7.3.3 Single-Use Technologies for the Biologic Sales, Revenue, Price and Gross Margin of GE Healthcare
- 7.4 Pall
- 7.4.1 Company profile
- 7.4.2 Representative Single-Use Technologies for the Biologic Product
- 7.4.3 Single-Use Technologies for the Biologic Sales, Revenue, Price and Gross Margin of Pall
- 7.5 BioPure Technology
- 7.5.1 Company profile
- 7.5.2 Representative Single-Use Technologies for the Biologic Product
- 7.5.3 Single-Use Technologies for the Biologic Sales, Revenue, Price and Gross Margin of BioPure Technology
- 7.6 Sartorius
- 7.6.1 Company profile
- 7.6.2 Representative Single-Use Technologies for the Biologic Product
- 7.6.3 Single-Use Technologies for the Biologic Sales, Revenue, Price and Gross Margin of Sartorius
- 7.7 Novasep
- 7.7.1 Company profile
- 7.7.2 Representative Single-Use Technologies for the Biologic Product
- 7.7.3 Single-Use Technologies for the Biologic Sales, Revenue, Price and Gross Margin of Novasep
- 7.8 W. L. Gore and Associates
- 7.8.1 Company profile
- 7.8.2 Representative Single-Use Technologies for the Biologic Product
- 7.8.3 Single-Use Technologies for the Biologic Sales, Revenue, Price and Gross Margin of W. L. Gore and Associates
- 7.9 EMD Millipore
- 7.9.1 Company profile
- 7.9.2 Representative Single-Use Technologies for the Biologic Product
- 7.9.3 Single-Use Technologies for the Biologic Sales, Revenue, Price and Gross Margin of EMD Millipore
- 7.10 DowDuPont
- 7.10.1 Company profile
- 7.10.2 Representative Single-Use Technologies for the Biologic Product
- 7.10.3 Single-Use Technologies for the Biologic Sales, Revenue, Price and Gross Margin of DowDuPont
Chapter 8 Upstream and Downstream Market Analysis of Single-Use Technologies for the Biologic
- 8.1 Industry Chain of Single-Use Technologies for the Biologic
- 8.2 Upstream Market and Representative Companies Analysis
- 8.3 Downstream Market and Representative Companies Analysis
Chapter 9 Cost and Gross Margin Analysis of Single-Use Technologies for the Biologic
- 9.1 Cost Structure Analysis of Single-Use Technologies for the Biologic
- 9.2 Raw Materials Cost Analysis of Single-Use Technologies for the Biologic
- 9.3 Labor Cost Analysis of Single-Use Technologies for the Biologic
- 9.4 Manufacturing Expenses Analysis of Single-Use Technologies for the Biologic
Chapter 10 Marketing Status Analysis of Single-Use Technologies for the Biologic
- 10.1 Marketing Channel
- 10.1.1 Direct Marketing
- 10.1.2 Indirect Marketing
- 10.1.3 Marketing Channel Development Trend
- 10.2 Market Positioning
- 10.2.1 Pricing Strategy
- 10.2.2 Brand Strategy
- 10.2.3 Target Client
- 10.3 Distributors/Traders List
Chapter 11 Report Conclusion
Chapter 12 Research Methodology and Reference
- 12.1 Methodology/Research Approach
- 12.1.1 Research Programs/Design
- 12.1.2 Market Size Estimation
- 12.1.3 Market Breakdown and Data Triangulation
- 12.2 Data Source
- 12.2.1 Secondary Sources
- 12.2.2 Primary Sources
Report Summary
Single-Use Technologies for the Biologic-Global Market Status and Trend Report 2016-2026 offers a comprehensive analysis on Single-Use Technologies for the Biologic industry, standing on the readers’ perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Worldwide and Regional Market Size of Single-Use Technologies for the Biologic 2016-2021, and development forecast 2022-2026
Main manufacturers/suppliers of Single-Use Technologies for the Biologic worldwide, with company and product introduction, position in the Single-Use Technologies for the Biologic market
Market status and development trend of Single-Use Technologies for the Biologic by types and applications
Cost and profit status of Single-Use Technologies for the Biologic, and marketing status
Market growth drivers and challengesSince the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency.The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Ammonium Single-Use Technologies for the Biologic market in 2020.COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.This report also analyses the impact of Coronavirus COVID-19 on the Single-Use Technologies for the Biologic industry.
The report segments the global Single-Use Technologies for the Biologic market as:
Global Single-Use Technologies for the Biologic Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2016-2026):
North America
Europe
China
Japan
Rest APAC
Latin America
Global Single-Use Technologies for the Biologic Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2016-2026):
Membrane Adsorber
Bioreactors
Disposable Mixing Systems
Tangential Flow Filtration
Tubing and Connectors
Depth Filtration
Buffer Containers
Waste Containers
Global Single-Use Technologies for the Biologic Market: Application Segment Analysis (Consumption Volume and Market Share 2016-2026; Downstream Customers and Market Analysis)
Monoclonal Antibodies
Vaccines
Gene Therapy
Recombinant Proteins
Blood Derivatives
Global Single-Use Technologies for the Biologic Market: Manufacturers Segment Analysis (Company and Product introduction, Single-Use Technologies for the Biologic Sales Volume, Revenue, Price and Gross Margin):
Thermo Fisher Scientific
Applikon Biotechnology
GE Healthcare
Pall
BioPure Technology
Sartorius
Novasep
W. L. Gore and Associates
EMD Millipore
DowDuPont
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.